Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

4-7-8 Breathing Exercises for Stress, Well-Being, and Quality of Life in Newly Diagnosed Type 2 Diabetes

14 novembre 2026 aggiornato da: EMRE ERKAL, Artvin Coruh University

Effects of 4-7-8 Breathing Exercises on Perceived Stress, Mental Well-Being, and Quality of Life in Newly Diagnosed Patients With Type 2 Diabetes

This randomized controlled trial aims to evaluate the effects of 4-7-8 breathing exercises on perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus.

The study will be conducted at the Internal Medicine Outpatient Clinic of Kayseri City Hospital, Türkiye. A total of 60 patients aged 18-65 years who have been newly diagnosed with type 2 diabetes mellitus and have HbA1c levels of 8% or higher will be enrolled. Participants will be randomly assigned to either the intervention group (n=30) or the control group (n=30) using simple randomization.

Participants in the intervention group will perform 4-7-8 breathing exercises twice daily, in the morning and evening, for four weeks, in addition to receiving routine diabetes treatment. The breathing technique involves inhaling through the nose for 4 seconds, holding the breath for 7 seconds, and exhaling through the mouth for 8 seconds. Participants will be instructed to perform four sets per session. Participants in the control group will continue receiving routine diabetes treatment without any additional breathing exercises.

Data will be collected at baseline and at the end of the four-week intervention using the Perceived Stress Scale (PSS-14), the World Health Organization-Five Well-Being Index (WHO-5), and the Short Form-36 Health Survey (SF-36).

The study will investigate whether 4-7-8 breathing exercises improve perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus compared with routine care alone.

Panoramica dello studio

Stato

Non ancora reclutamento

Descrizione dettagliata

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that requires continuous treatment, lifestyle modifications, and self-management. Receiving a new diagnosis of T2DM may lead to psychological distress, uncertainty, and difficulties adapting to disease-related responsibilities. These challenges may negatively affect perceived stress, mental well-being, and quality of life during the early stages of disease management.

Controlled breathing exercises are non-pharmacological interventions that may help regulate physiological and psychological responses to stress. The 4-7-8 breathing technique involves a structured breathing pattern designed to promote relaxation through controlled inhalation, breath-holding, and prolonged exhalation. Although previous studies have investigated various breathing techniques in individuals with T2DM, evidence regarding the effects of 4-7-8 breathing exercises specifically in newly diagnosed patients remains limited.

This study is designed as a two-arm, parallel-group randomized controlled trial to investigate the effectiveness of 4-7-8 breathing exercises as a complementary intervention alongside routine diabetes treatment.

Following eligibility assessment and informed consent, participants will complete baseline assessments and be randomly allocated to the intervention or control group. Participants assigned to the intervention group will receive instructions on performing the 4-7-8 breathing technique and will practice the exercises twice daily for four weeks. Participants in both groups will continue their routine diabetes treatment throughout the study.

The study will assess three patient-reported outcomes: perceived stress, mental well-being, and health-related quality of life. Perceived stress will be evaluated using the 14-item Perceived Stress Scale (PSS-14), with higher scores indicating greater perceived stress. Mental well-being will be assessed using the WHO-5 Well-Being Index, with higher scores indicating better well-being. Health-related quality of life will be measured using the SF-36 Health Survey, which evaluates eight dimensions of physical and mental health.

Outcome assessments will be conducted at baseline and after the four-week intervention. The collected data will be analyzed using appropriate statistical methods to examine changes within groups and differences between groups.

The findings are expected to contribute to the evidence regarding the potential role of 4-7-8 breathing exercises as a simple, accessible, and non-pharmacological supportive intervention for patients newly diagnosed with T2DM.

Tipo di studio

Interventistico

Iscrizione (Stimato)

60

Fase

  • Non applicabile

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Being between 18 and 65 years of age.
  • Having a new diagnosis of type 2 diabetes mellitus.
  • Having an HbA1c level of ≥8%.
  • Having initiated insulin and/or oral antidiabetic treatment.
  • Having no communication difficulties.
  • Having no respiratory disorders (e.g., asthma or chronic obstructive pulmonary disease).
  • Being willing to participate in the study.

Exclusion Criteria:

  • Presence of respiratory disorders, such as asthma or chronic obstructive pulmonary disease (COPD).
  • Presence of communication difficulties that prevent participation in the study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: 4-7-8 Breathing Exercise Group

Participants in the experimental group will perform 4-7-8 breathing exercises twice daily (morning and evening), with four sets per session, for four weeks. Each breathing cycle consists of inhaling through the nose for 4 seconds, holding the breath for 7 seconds, and exhaling slowly through the mouth for 8 seconds. Participants will continue receiving their routine diabetes treatment throughout the intervention period.

Participants in the intervention group will perform the 4-7-8 breathing exercise for four weeks in addition to their routine diabetes treatment. The technique consists of three consecutive steps: (1) exhaling completely through the mouth while making a whooshing sound; (2) closing the mouth, inhaling quietly through the nose for 4 seconds, and holding the breath for 7 seconds; and (3) exhaling slowly through the mouth for 8 seconds while making a whooshing sound. Participants will be instructed to perform the exercise twice daily, in the morning and evening, with four sets per session. Routine diabetes treatment will continue throughout the intervention period.

Nessun intervento: Routine Care Group

Participants in the control group will continue receiving routine diabetes treatment without performing 4-7-8 breathing exercises or receiving any additional breathing intervention during the four-week study period.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Perceived Stress Scale (PSS-14) Score From Baseline to Week 4
Lasso di tempo: Baseline, Week 4

Perceived stress will be assessed using the 14-item Perceived Stress Scale (PSS-14). Each item is rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often). Total scores range from 0 to 56, with higher scores indicating greater perceived stress. The outcome will be assessed as the change in total PSS-14 score from baseline to Week 4. A decrease in the total score indicates a reduction in perceived stress.

Baseline, Week 4

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in WHO-5 Well-Being Index Score From Baseline to Week 4
Lasso di tempo: Baseline, Week 4

Mental well-being will be assessed using the World Health Organization-Five Well-Being Index (WHO-5). The instrument consists of five items, each scored from 0 (at no time) to 5 (all of the time). The raw total score ranges from 0 to 25, with higher scores indicating better mental well-being. The outcome will be assessed as the change in the raw total WHO-5 score from baseline to Week 4. An increase in the score indicates improved mental well-being.

Baseline, Week 4
Secondary Outcome 2 - Quality of Life (SF-36)
Lasso di tempo: Baseline, Week 4

Health-related quality of life will be assessed using the 36-Item Short Form Health Survey (SF-36). The instrument consists of 36 items evaluating eight domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored separately from 0 to 100, with higher scores indicating better health-related quality of life. Changes in the eight domain scores from baseline to Week 4 will be evaluated. The SF-36 does not provide a single overall total score.

Baseline, Week 4

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

16 novembre 2026

Completamento primario (Stimato)

16 novembre 2027

Completamento dello studio (Stimato)

16 novembre 2027

Date di iscrizione allo studio

Primo inviato

10 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

14 novembre 2026

Primo Inserito (Effettivo)

17 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi